NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/07/2025
Back to search
Official data from USPTO
OPTIDART
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
45
Latest update
02/08/2025
Trademark type
Word
Nice classes
5
Filing date
05/17/2019
Registration date
12/28/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/28/2021
Last transaction
02/08/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
98
Owner location
KR
Examiner
O'BRIEN, JENNIFER
Law office
N20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Genexine, Inc.
Representatives
James R Menker Holley & Menker, PA
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for regulating the immune system; pharmaceutical products for the treatment of viral diseases; vaccines; adjuvants for use with vaccines; vaccine preparations; anti-inflammatories; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations for the treatment of inflammatory diseases; nucleic acid sequences for medical and veterinary purposes; diagnostic preparations for medical purposes for detecting mutation in prion genes; chemical preparations for use in DNA analysis for medical purposes; reagents for use in medical genetic testing; human vaccine preparations; pharmaceutical preparations for the treatment of cervical intraepithelial neoplasia; pharmaceutical preparations for the treatment of immune system related diseases and disorders; anti-asthmatic agentspharmaceutical preparations for the treatment of asthmatic disorders; dermatological pharmaceutical products; antibiotic preparations; biological preparationsantibody fusion proteins for the treatment of cancer
Publications
History of USPTO decisions and trademark events.
45 publications found
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
11/28/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/05/2022
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/10/2022
FIMP
FINAL DISPOSITION PROCESSED
06/09/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/28/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
12/28/2021
GPNX
NOTIFICATION PROCESSED BY IB
10/24/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/12/2021
PUBO
PUBLISHED FOR OPPOSITION
10/12/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/22/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
09/22/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/22/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/06/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/26/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/26/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/26/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/14/2021
GNRT
NON-FINAL ACTION E-MAILED
07/14/2021
CNRT
NON-FINAL ACTION WRITTEN
07/14/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/26/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/26/2021
ALIE
ASSIGNED TO LIE
05/25/2021
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
05/19/2021
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
01/30/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/13/2021
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
01/13/2021
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
11/12/2020
ALIE
ASSIGNED TO LIE
11/12/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/28/2020
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
04/01/2020
GNSL
LETTER OF SUSPENSION E-MAILED
04/01/2020
CNSL
SUSPENSION LETTER WRITTEN
04/01/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/07/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/07/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/07/2020
RFNT
REFUSAL PROCESSED BY IB
09/28/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/11/2019
RFRR
REFUSAL PROCESSED BY MPU
09/11/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/27/2019
CNRT
NON-FINAL ACTION WRITTEN
08/26/2019
MAFR
APPLICATION FILING RECEIPT MAILED
08/24/2019
DOCK
ASSIGNED TO EXAMINER
08/20/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/20/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/08/2019
Continuous trademark protection
Get notified about every new filing that threatens OPTIDART or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.